CPSC recall · Reported March 18, 2021
Genentech Recalls Prescription Drug Evrysdi Due to Failure to Meet Child Resistant Packaging Requirements; Risk of Drug Exposure through Eye or Skin Absorption (Recall Alert)
The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug expo…
Genentech, a member of the Roche Group, of South San Francisco, Calif. recalled This recall involves bottles of the prescription drug Evrysdi, a prescription medicine us….
Genentech Recalls Prescription Drug Evrysdi Due to Failure to Meet Child Resistant Packag… was recalled by Genentech, a member of the Roche Group, of South San Francisco, Calif. in March 18, 2021. Reason: The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter …. Remedy: Consumers should immediately store Evrysdi in a safe location out of reach and sight of c…. Verify recall #21729 with the CPSC before acting.
The recall
Genentech, a member of the Roche Group, of South San Francisco, Calif. issued this CPSC recall-The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter ….
- None
- agency class
- March 18, 2021
- reported
Sourced from official CPSC enforcement records. Verify recall #21729 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. Consumers holding this product should act on the agency's documented remedy above rather than relying on general guidance.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Drugs & Medications recalls over time
Where this recall sits in its category - 14,472 drugs & medications recalls on record
Product description
This recall involves bottles of the prescription drug Evrysdi, a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older. The recalled 100 mL amber bottles have "Evrysdi (risdiplam) for oral solution," the dosage and "NDC 20242-175-07" on the front of the bottle labels.
Reason for recall
The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
Remedy, what to do
Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Consumer Product Safety Commission |
| Severity class | Not classified by agency |
| Status | Active |
| Recall number | 21729 |
| Date reported | March 18, 2021 |
| Date initiated | March 18, 2021 |
| Recalling firm | Genentech, a member of the Roche Group, of South San Francisco, Calif. |
| Affected scope | About 14,000 |
| Distribution | Not disclosed |
| Official source | CPSC notice → |
Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.
What to do with this recall
Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bo…
- Check the recall number (21729) and product description against the item you own. Search the archive
- Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
Why was this product recalled? ▼
What should consumers do? ▼
Which agency issued this recall? ▼
How do I report an injury from a recalled product? ▼
Nationwide recalls with similar severity or category timing
Consumer-product notices outside this firm and state, matched by severity timing and product category.
Similar severity · nearest report date
Same archive severity grade, closest by report date among other firms and states.
Similar Drugs & Medications · nearest report date
Same product category, closest by report date among other firms and states (deduped against the severity set).
Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls
Methodology · Corrections · Archive as of August 2026